<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Braz J Cardiovasc Surg</journal-id><journal-id journal-id-type="iso-abbrev">Braz J Cardiovasc Surg</journal-id><journal-id journal-id-type="publisher-id">rbccv</journal-id><journal-title-group><journal-title>Brazilian Journal of Cardiovascular Surgery</journal-title></journal-title-group><issn pub-type="ppub">0102-7638</issn><issn pub-type="epub">1678-9741</issn><publisher><publisher-name>Sociedade Brasileira de Cirurgia Cardiovascular</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">29617502</article-id><article-id pub-id-type="pmc">5873774</article-id><article-id pub-id-type="doi">10.21470/1678-9741-2017-0049</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Article</subject></subj-group></article-categories><title-group><article-title>The Frequency of Infective Endocarditis in <italic>Candida</italic>
Bloodstream Infections: a Retrospective Study in a Child
Hospital</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Kara</surname><given-names>Ahu</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="corresp" rid="c1"/><role>MD</role></contrib><contrib contrib-type="author"><name><surname>Devrim</surname><given-names>&#x00130;lker</given-names></name><xref ref-type="aff" rid="aff1">1</xref><role>MD</role></contrib><contrib contrib-type="author"><name><surname>Me&#x0015f;e</surname><given-names>Timur</given-names></name><xref ref-type="aff" rid="aff1">1</xref><role>MD</role></contrib><contrib contrib-type="author"><name><surname>Bayram</surname><given-names>Nuri</given-names></name><xref ref-type="aff" rid="aff1">1</xref><role>MD</role></contrib><contrib contrib-type="author"><name><surname>Y&#x00131;lmazer</surname><given-names>Murat</given-names></name><xref ref-type="aff" rid="aff1">1</xref><role>MD</role></contrib><contrib contrib-type="author"><name><surname>G&#x000fc;lfidan</surname><given-names>Gamze</given-names></name><xref ref-type="aff" rid="aff1">1</xref><role>MD</role></contrib><aff id="aff1">
<label>1</label> Department of Pediatric Infectious Diseases, Dr. Beh&#x000e7;et
Uz Children's Hospital, &#x00130;zmir, Turkey. </aff></contrib-group><author-notes><corresp id="c1">Correspondence Address: Ahu Kara, Dr. Beh&#x000e7;et Uz Children's
Hospital - Pediatric Infectious Diseases, Ismet Kaptan Street, 11, Konak
&#x00130;zmir, Turkey - 35100. E-mail: <email>ahukara01@hotmail.com</email></corresp></author-notes><pub-date pub-type="epub-ppub"><season>Jan-Feb</season><year>2018</year></pub-date><!--Fake ppub date generated by PMC from publisher
							pub-date/@pub-type='epub-ppub' --><pub-date pub-type="ppub"><season>Jan-Feb</season><year>2018</year></pub-date><volume>33</volume><issue>1</issue><fpage>54</fpage><lpage>58</lpage><history><date date-type="received"><day>12</day><month>1</month><year>2017</year></date><date date-type="accepted"><day>21</day><month>3</month><year>2017</year></date></history><permissions><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an Open Access article distributed under the terms of the
Creative Commons Attribution License, which permits unrestricted use,
distribution, and reproduction in any medium, provided the original work is
properly cited.</license-p></license></permissions><abstract><sec><title>Introduction</title><p>Fungal endocarditis is reported less frequently than bacterial endocarditis,
with an incidence of 0-12% of the total pediatric infective
endocarditis.</p></sec><sec><title>Objective</title><p>In this study, the incidence of infective endocarditis in
<italic>Candida</italic> bloodstream infections in a tertiary hospital
during the periods of 2007 and 2016 was reviewed.</p></sec><sec><title>Methods</title><p>Patients with positive blood or catheter cultures in terms of <italic>Candida
spp.</italic> during the study period of January 2007 and January 2016
were analyzed in terms of <italic>Candida</italic> infective endocarditis.
Infective endocarditis was defined according to the modified Duke criteria.
The outcome, possible associated predisposing factors for
<italic>Candida</italic> endocarditis were determined.</p></sec><sec><title>Results</title><p>221 patients and 256 attacks with positive blood or catheter cultures in
terms of <italic>Candida</italic> were included in the study. The most
common <italic>Candida</italic> species was <italic>Candida
parapsilosis</italic>, isolated in 157 (61.3%) attacks, followed by
<italic>Candida albicans</italic> in 70 (27.3%). Neurological diseases
(23%), hemato-oncological diseases (12.1%), previously known heart diseases
(8.2%), inborn errors of metabolism (9%) were common comorbidities. Twelve
(5.4%) patients had a previous history of cardiac surgery. Among the 221
patients, <italic>Candida endocarditis</italic> was present in only two
(0.9%) of them.</p></sec><sec><title>Conclusion</title><p>Although <italic>Candida</italic> infective endocarditis is an uncommon but
frequently fatal infection in pediatrics, echocardiography should be
performed routinely for patients with positive blood or catheter cultures in
terms of <italic>Candida</italic>. Prompt and effective antimicrobial
therapy might prevent cardiac surgery in selected cases, however this could
not be a general rule for all patients.</p></sec></abstract><kwd-group><kwd>Infection</kwd><kwd>Candida</kwd><kwd>Endocarditis</kwd></kwd-group></article-meta></front><body><table-wrap id="t2" orientation="portrait" position="anchor"><table frame="hsides" rules="groups"><colgroup span="1"><col width="5%" span="1"/><col width="43%" span="1"/><col width="3%" span="1"/><col width="5%" span="1"/><col width="43%" span="1"/></colgroup><thead><tr><th align="left" colspan="2" style="background-color:#e6e7e8" rowspan="1">Abbreviations,
acronyms &#x00026; symbols</th><th align="center" rowspan="1" colspan="1">&#x000a0;</th><th align="center" colspan="2" style="background-color:#e6e7e8" rowspan="1">&#x000a0;</th></tr></thead><tbody><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">ASD</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Atrial septal
defect</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">MR</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Mitral
regurgitation</td></tr><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">BSIs</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Bloodstream
infections</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">PE</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Pericardial
effusion</td></tr><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">CMP</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Cardiomyopathy</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">PFO</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Patent foramen
ovale</td></tr><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">CVC</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Central venous
catheter</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">PS</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Pulmonary stenosis</td></tr><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">ESCMID</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= European Society of
Clinical Microbiology and Infectious Diseases</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">SPSS</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Statistical Package for
the Social Sciences</td></tr><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">FE</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Fungal endocarditis</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">TEE</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Transesophageal
echocardiography</td></tr><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">ICUs</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Intensive care
units</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">TGA</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Transposition of the
great arteries</td></tr><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">IDSA</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Infectious Diseases
Society of America</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">TOF</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Tetralogy of Fallot</td></tr><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">IE</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Infective
endocarditis</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">TR</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Tricuspid
regurgitation</td></tr><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">&#x000a0;</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">VSD</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Ventricular septal
defect</td></tr></tbody></table></table-wrap><sec sec-type="intro"><title>INTRODUCTION</title><p>Infective endocarditis (IE) is the most common and fatal form of endovascular
infections. Fungal endocarditis (FE) is reported less frequently than bacterial
endocarditis, with an incidence of 0-12% of the total pediatric IE
admissions<sup>[<xref rid="r1" ref-type="bibr">1</xref>,<xref rid="r2" ref-type="bibr">2</xref>]</sup>. <italic>Candida</italic>
species were reponsible of the two thirds of FE. <italic>Candida</italic> IE is a
rare and poorly understood complication of fungemia. Prolonged fever and changing
heart murmur are the most common clinical manifestations. The most frequently
reported risk factors for FE are previous surgery, indwelling foreign bodies such as
catheters, antibiotic use, underlying heart disease, prosthetic valves, and
immunocompromising conditions<sup>[<xref rid="r1" ref-type="bibr">1</xref>,<xref rid="r3" ref-type="bibr">3</xref>,<xref rid="r4" ref-type="bibr">4</xref>]</sup>. The recommended treatment of
<italic>Candida</italic> IE is an amphotericin B-based regimen plus surgical
intervention, often followed by long-term fluconazole for
suppression<sup>[<xref rid="r5" ref-type="bibr">5</xref>]</sup>. Despite aggressive antifungal and surgical therapy,
mortality from <italic>Candida</italic> endocarditis was reported between
30-80%<sup>[<xref rid="r6" ref-type="bibr">6</xref>-<xref rid="r12" ref-type="bibr">12</xref>]</sup>. Therefore, clinicians
should be alert for early diagnosis and prompt treatment of FE.</p><p>The aim of this study was to determine the incidence of <italic>IE</italic> in
<italic>Candida</italic> bloodstream infections (BSIs) in a tertiary hospital
during the periods of 2007 and 2016.</p></sec><sec sec-type="methods"><title>METHODS</title><sec><title>Study Design</title><p>Data for this study were derived from hospitalized patients between January 2007
and January 2016 in Dr Beh&#x000e7;et Uz Children Diseases and Surgery Training
and Research Hospital. Demographic data included age, gender, patients ward,
echocardiography findings, presence of an indwelling central venous catheter
(CVC), cause of hospitalization, presence of underlying disease, type of
<italic>Candida</italic> in positive blood and/or catheter cultures,
presence of fluconazole prophylaxis, presence of previous cardiac surgery and
prosthetic valve, presence of mechanical ventilation. Data were recorded from
medical records.</p></sec><sec><title>Study Population</title><p>Patients were included in this study if they had two or more positive blood or
catheter cultures in terms of <italic>Candida</italic> If the same patient had
an attack of candidemia again at least 3 weeks after 3 consecutive negative
blood or catheter cultures for <italic>Candida</italic>, this was accepted as a
new attack.</p></sec><sec><title>Definitions</title><p><italic>IE</italic> was defined according to the modified Duke
criteria<sup>[<xref rid="r13" ref-type="bibr">13</xref>,<xref rid="r14" ref-type="bibr">14</xref>]</sup>.</p><p>A definitive clinical diagnosis was done based on the following criteria: 2 major
criteria or 1 major criteria and 3 minor criteria or 5 minor criteria (<xref ref-type="table" rid="t1">Table 1</xref>).</p><table-wrap id="t1" orientation="portrait" position="float"><label>Table 1</label><caption><p>Modified Duke criteria.</p></caption><table frame="hsides" rules="all"><colgroup span="1"><col width="33%" span="1"/><col width="33%" span="1"/><col width="33%" span="1"/></colgroup><thead><tr><th align="center" rowspan="1" colspan="1">Major blood culture criteria</th><th align="center" rowspan="1" colspan="1">Major echocardiographic criteria</th><th align="center" rowspan="1" colspan="1">Minor criteria</th></tr></thead><tbody><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02022; Two blood cultures positive
for organisms typically found in patients with
IE<break/>&#x02022; Blood cultures persistently positive for one
of these organisms, from cultures drawn more than 12 hours
apart<break/>&#x02022; Three or more separate blood cultures
drawn at least 1 hour apart</td><td align="left" valign="top" rowspan="1" colspan="1">&#x02022; Echocardiogram positive for
IE, documented by an oscillating intracardiac mass on a valve or
on supporting structures, in the path of regurgitant jets, or on
implanted material, in the absence of an alternative anatomic
explanation<break/>&#x02022; Myocardial abscess<break/>&#x02022;
Development of partial dehiscence of a prosthetic
valve<break/>&#x02022; New-onset valvular regurgitation</td><td align="left" valign="top" rowspan="1" colspan="1">&#x02022; Predisposing heart condition
or intravenous drug use<break/> &#x02022; Fever of 38&#x000ba;C
(100.4&#x000ba;F) or higher<break/>&#x02022; Vascular phenomenon,
including major arterial emboli, septic pulmonary infarcts,
mycotic aneurysm, intracranial hemorrhage, conjunctival
hemorrhage, or Janeway lesions<break/>&#x02022; Immunologic
phenomenon such as glomerulonephritis, Osler nodes, Roth spots,
and rheumatoid factor<break/>&#x02022; Positive blood culture
results not meeting major criteria or serologic evidence of
active infection with an organism consistent with
IE<break/>&#x02022; Echocardiogram results consistent with IE but
not meeting major echocardiographic criteria</td></tr></tbody></table></table-wrap></sec><sec><title>Statistical Analysis</title><p>All statistical analyses were performed using Statistical Package for the Social
Sciences version 18.0 (SPSS, Microsoft Inc., Chicago, Il, USA). Patients'
demographics and clinical variables were described as mean, median (if not
normally distributed), and standard deviation for continuous data and
proportions for nominal and ordinal data.</p></sec></sec><sec sec-type="results"><title>RESULTS</title><p>Two hundred and twenty-one patients and 256 attacks with positive blood or catheter
cultures in terms of <italic>Candida</italic> were included in the study. One
hundred and twenty-nine (58.4%) of patients were male, 92 (41.6%) were female. The
median age of the patients was 10.0 months (ranging from 7 days of age to 17 years).
One hundred and eighty-six (72.6%) attacks had been observed in patients
hospitalized in intensive care units (ICUs) and 70 (27.4%) attacks in our study in
other wards in stead of ICUs.</p><p>Most common <italic>Candida</italic> species was <italic>Candida
parapsilosis</italic> isolated in 157 (61.3%) attacks followed by
<italic>Candida albicans</italic> in 70 (27.3%), <italic>Candida
tropicalis</italic> in 16 (6.3%), <italic>Candida lusitaniae</italic> in five
(2%), <italic>Candida glabrata</italic> in three (1.2%), <italic>Candida
guilermondii</italic> in two (0.8%), <italic>Candida ciferrii</italic> in two
(0.8%) and <italic>Candida dublinensis</italic> in one (0.4%). Distribution
according to types of <italic>Candida</italic> in blood cultures was reviewed in
<xref ref-type="fig" rid="f1">Figure 1</xref>. The catheter-related BSIs were
present in 133 attacks. One hundred and seven (80.4%) patients were positive for
<italic>Candida parapsilosis</italic>, 15 (11.2%) for <italic>Candida
albicans</italic>, six (4.5%) for <italic>Candida tropicalis</italic>, two
(1.5%) for <italic>Candida lusitaniae</italic>, two (1.5%) for <italic>Candida
glabrata</italic> and one (0.7%) for <italic>Candida guilermondii</italic>.
Distribution according to types of <italic>Candida</italic> in catheter cultures was
reviewed in <xref ref-type="fig" rid="f1">Figure 1</xref>.</p><p>
<fig id="f1" orientation="portrait" position="float"><label>Fig. 1</label><caption><p>Distribution according to isolated Candida species in blood cultures and
catheter cultures.</p></caption><graphic xlink:href="rbccv-33-01-0054-g01"/></fig>
</p><p>An indwelling CVC was present in 117 (47.1%) patients. Seventy-six (29.7%) patients
were receiving fluconazole prophylaxis at the time of positive blood or catheter
culture during attacks. Among 221 patients, 12 (5.4%) had cardiac surgery, including
complex intracardiac repairs (7), palliative shunt procedures (4) and prosthetic
valve (1). Approximately half of the patients (52.3%) had underlying diseases,
including 59 (23%) neurological diseases, 31 (12.1%) hemato-oncological diseases, 21
(8.2%) previously known congenital heart diseases, and 23 (9%) inborn errors of
metabolism.</p><p>Echocardiography had been performed in all patients. In echocardiography, normal
cardiac findings were present in 151 (68.4%) patients, while 31 (14.8%) patients had
atrial septal defect (ASD) and/or ventricular septal defect (VSD), 18 (8.1%)
patients had patent foramen ovale (PFO) and seven (3.2%) had tricuspid regurgitation
(TR). More rare findings were cardiomyopathy (CMP) in three (1.4%), tetralogy of
Fallot (TOF) in two (0.9%), pericardial effusion (PE) in two (0.9%), transposition
of the great arteries (TGA) in two (0.9%), mitral regurgitation (MR) in two (0.9%),
and pulmonary stenosis (PS) in one (0.5%) patient. The distribution according to the
echocardiography was summarized in <xref ref-type="fig" rid="f2">Figure
2</xref>.</p><p>
<fig id="f2" orientation="portrait" position="float"><label>Fig. 2</label><caption><p>Distribution according to echocardiography.</p><p>ASD&#x000b1;VSD=atrial septal defect and/or ventricular septal defect;
CMP=cardiomyopathy; MR=mitral regurgitation; normal: normal
echocardiogram findings; PE=pericardial effusion; PFO=patent foramen
ovale; PS=pulmonary stenosis; TGA=transposition of the great arteries;
TOF=tetralogy of Fallot; TR=tricuspid regurgitation</p></caption><graphic xlink:href="rbccv-33-01-0054-g02"/></fig>
</p><p>Among the 221 patients, <italic>Candida</italic> endocarditis was detected in only
two (0.9%) patients. One of the patients was a 9-yearold boy with cerebral palsy who
was presented at our hospital with cough, tachypnea and fever. He was admitted to
the ICU with severe pneumonia. On the 14<sup>th</sup> day of his treatment,
echocardiography revealed an echogenic mass of 50x40 mm attached to the wall of the
left internal jugular vein. <italic>Candida albicans</italic> was isolated from two
consecutive blood cultures. Meropenem, vancomycin and amphotericin B therapy were
initiated for the treatment of IE. <italic>C. albicans</italic> was reported as
susceptible to caspofungin, amphotericin B and fluconazole. Cardiac surgery was
planned due to the patient's status. However, due to the response to antifungal
medical treatment and improvement in his clinic and the recovery of intracardiac
mass, surgical treatment was postponed.</p><p>The other patient was a 5-month-old girl who was presented to our hospital with
dyspnea and high-grade fever. She had a medical history of secundum ASD and
perimembranous VSD which had been closed with the Amplatzer(tm) Septal Occluder with
angiography 2 months ago. She was transferred into pediatric ICU and her first
echocardiography revealed pulmonary hypertension and the subclavian venous catheter
was inserted into the patient. Her first blood culture was sterile. On the fifth day
of treatment, two-dimensional echocardiography showed a 30x25 mm heterogenous mass
attached to the right atrium wall. Piperacillintazobactam, vancomycin and gentamicin
therapy were initiated for the treatment of IE. <italic>Candida
parapsilosis</italic> was isolated from two different blood and CVC cultures.
<italic>C. parapsilosis</italic> has been reported to be susceptible to
caspofungin, amphotericin B and fluconazole, and caspofungin was initiated as the
initial antifungal therapy. On the seventh day of the antifungal therapy, the fever
returned and the consecutive echocardiography revealed a slowly resolving mass. Due
to the improved patient status, cardiac surgery was delayed. On the 45<sup>th</sup>
day of antifungal therapy, the echocardiography revealed complete resolution and the
patient was discharged from the hospital. After discharge, the patient received a
long-term (6 weeks) intermittent suppressive oral fluconazole (9 mg/kg/day)
therapy.</p></sec><sec sec-type="discussion"><title>DISCUSSION</title><p>Fungemia rates have increased significantly in recent years, resulting in a growing
number of populations at risk for this disease<sup>[<xref rid="r9" ref-type="bibr">9</xref>,<xref rid="r15" ref-type="bibr">15</xref>]</sup>.
Fungal endocarditis is an uncommon infection and predominantly caused by
<italic>Candida</italic> species, and less frequently by
<italic>Aspergillus</italic> species. Invasive candidiasis was a major cause of
morbidity and mortality in children. Historically, <italic>C. albicans</italic> has
been the most common isolate from fungal BSIs<sup>[<xref rid="r16" ref-type="bibr">16</xref>]</sup>. Recently, there has been a reported
increase in the incidence of nonalbicans <italic>Candida spp.</italic>, especially
of <italic>C. parapsilosis</italic>
<sup>[<xref rid="r17" ref-type="bibr">17</xref>-<xref rid="r21" ref-type="bibr">21</xref>]</sup>, whose incidence could change according to
hospitals. According to our data in the study, C<italic>. parapsilosis</italic> was
the most dominant candida in <italic>Candida</italic> BSIs.</p><p>FE has been reported to cause 0-12% (average 1.1%) of the total IE cases in children
worldwide. The incidence rate is approximately 1.5-4 cases per 10 million
children<sup>[<xref rid="r22" ref-type="bibr">22</xref>]</sup>. In our hospital, 15 patients with IE had been identifed
according to modified Duke criteria during the study period. As a result, the ratio
of FE cases in all IE cases diagnosed in our hospital was 13.3%, which is slightly
higher than the literature. Puig-Asensio et al.<sup>[<xref rid="r23" ref-type="bibr">23</xref>]</sup> reported that incidence of IE in
<italic>Candida</italic> BSIs was 1.9% (14/512 patients with candidemia), which
was relatively high compared to our findings. The reported cases of FE were less
than a few hundred in patients of any age, while two thirds of FE were associated
with <italic>Candida</italic> species. <italic>Candida</italic> IE is an uncommon
but frequently fatal infection in pediatrics with the survival rate remains below
25%<sup>[<xref rid="r1" ref-type="bibr">1</xref>,<xref rid="r10" ref-type="bibr">10</xref>]</sup>.</p><p>Our patients have multiple possible risk factors for developing FE, including
prolonged ICU stay, prolonged use of intravenous antibiotics, underlying heart
disease (ASD and VSD), previous cardiac surgery, and presence of CVC. In addition,
immunocompromising conditions were well-defined risk factors for developing
FE<sup>[<xref rid="r1" ref-type="bibr">1</xref>,<xref rid="r10" ref-type="bibr">10</xref>,<xref rid="r11" ref-type="bibr">11</xref>]</sup>.
Multifactorial risk factors in a single patient might be more likely to cause
FE<sup>[<xref rid="r24" ref-type="bibr">24</xref>]</sup>.
Repaired congenital heart disease with residual defects and the first six months of
repaired congenital heart disease with no residual defects are at risk of
IE<sup>[<xref rid="r9" ref-type="bibr">9</xref>]</sup>. The
second patient's heart defects were closed with Septal Occluder with angiography 2
months ago. A&#x0011f;&#x00131;n et al.<sup>[<xref rid="r3" ref-type="bibr">3</xref>]</sup> reported in their study the longer pediatric ICU
stays, mechanical ventilation, CVC, total parenteral nutrition were the risk factors
for the development of <italic>Candida</italic> infections in pediatric ICU.
However, studies for risk factors especially for FE were limited, while risk factors
for <italic>Candida</italic> BSIs were well-defined.</p><p>FE typically occurs in otherwise critically ill patients and is often part of a
confusing clinical picture, with most patients having difficulty meeting the Duke
criteria for IE<sup>[<xref rid="r25" ref-type="bibr">25</xref>]</sup>.
Transthoracic echocardiography is less sensitive than transesophageal
echocardiography (TEE), but is also less invasive. Intracardiac vegetations and
thrombi are the most common types, but are still rare<sup>[<xref rid="r9" ref-type="bibr">9</xref>,<xref rid="r22" ref-type="bibr">22</xref>]</sup>. Although these findings have rarely been observed,
both of our patients had echogenic masses which could be visualized with
transthoracic echocardiography.</p><p>The guidelines of Infectious Diseases Society of America (IDSA) and European Society
of Clinical Microbiology and Infectious Diseases (ESCMID) for treatment of
<italic>Candida</italic> IE recommend either an amphotericin B-based regimen or
an echinocandin-based regimen, both in combination with adjunctive surgical therapy
if possible<sup>[<xref rid="r26" ref-type="bibr">26</xref>-<xref rid="r28" ref-type="bibr">28</xref>]</sup>. Fluconazole therapy has
been less successful than other agents<sup>[<xref rid="r27" ref-type="bibr">27</xref>]</sup>. In almost all reported cases of survival, surgical
management was necessary to supplement antifungal medical therapy. Surgery is
mandatory in the majority of cases and it is agreed that it should be performed as
early as possible<sup>[<xref rid="r26" ref-type="bibr">26</xref>]</sup>. In one patient with IE, the surgery was planned,
however, the surgical treatment was delayed due to recovery with medical antifungal
treatment. Current guidelines for endocarditis recommend initial or induction
therapy with Amphotericin B with or without flucytosine combined with surgical
removal of vegetation, followed by chronic suppressive therapy with oral
fluconazole<sup>[<xref rid="r29" ref-type="bibr">29</xref>,<xref rid="r30" ref-type="bibr">30</xref>]</sup>.</p><p><italic>Candida</italic> IE is associated with a high mortality rate that was not
affected by the choice of antifungal therapy or by adjunctive surgical
intervention<sup>[<xref rid="r31" ref-type="bibr">31</xref>]</sup>. Recently published article by Arnold et
al.<sup>[<xref rid="r32" ref-type="bibr">32</xref>]</sup>
demonstrated that mortality did not differ between those undergoing surgical therapy
and those receiving medical therapy alone. In another study, among 33 cases derived
from the International Collaboration of Endocarditis-Prospective Cohort Study, the
mortality rate was similar whether surgery was performed or not<sup>[<xref rid="r8" ref-type="bibr">8</xref>]</sup>. In contrast, Lefort et
al.<sup>[<xref rid="r9" ref-type="bibr">9</xref>]</sup>
suggested that early cardiac surgery during <italic>Candida</italic> IE should
always be attempted, and only patients with very poor medical status might not be
operated on according to the findings in their study.</p></sec><sec sec-type="conclusions"><title>CONCLUSION</title><p>FE is often difficult to diagnose, therefore, echocardiography should be performed
routinely for patients with positive blood or catheter cultures in terms of
<italic>Candida</italic> and TEE should be performed in the presence of
underlying clinical risk factors and high clinical suspicions.</p><table-wrap id="t3" orientation="portrait" position="anchor"><table frame="hsides" rules="groups"><colgroup span="1"><col width="5%" span="1"/><col width="95%" span="1"/></colgroup><thead><tr><th align="left" colspan="2" rowspan="1">Authors' roles &#x00026; responsibilities</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">AK</td><td align="left" rowspan="1" colspan="1">Concept, acquisition, analysis, interpretation of data
for the work; final approval of the version to be published</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x00130;D</td><td align="left" rowspan="1" colspan="1">Concept, acquisition, analysis, interpretation of data
for the work; revising; final approval of the version to be
published</td></tr><tr><td align="left" rowspan="1" colspan="1">TM</td><td align="left" rowspan="1" colspan="1">Analysis; final approval of the version to be
published</td></tr><tr><td align="left" rowspan="1" colspan="1">NB</td><td align="left" rowspan="1" colspan="1">Analysis; final approval of the version to be
published</td></tr><tr><td align="left" rowspan="1" colspan="1">MY</td><td align="left" rowspan="1" colspan="1">Revising; final approval of the version to be
published</td></tr><tr><td align="left" rowspan="1" colspan="1">GG</td><td align="left" rowspan="1" colspan="1">Final approval of the version to be published</td></tr></tbody></table></table-wrap></sec></body><back><fn-group><fn fn-type="other"><p>This study was carried out at the Department of Pediatric Infectious Diseases,
Dr. Beh&#x000e7;et Uz Children's Hospital, &#x00130;zmir, Turkey.</p></fn><fn fn-type="COI-statement"><p>No conflict of interest</p></fn></fn-group><fn-group><fn fn-type="financial-disclosure"><p>No financial support.</p></fn><fn fn-type="COI-statement"><p>No conflict of interest</p></fn></fn-group><ref-list><title>REFERENCES</title><ref id="r1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ellis</surname><given-names>ME</given-names></name><name><surname>Al-Abdely</surname><given-names>H</given-names></name><name><surname>Sandridge</surname><given-names>A</given-names></name><name><surname>Greer</surname><given-names>W</given-names></name><name><surname>Ventura</surname><given-names>W</given-names></name></person-group><article-title>Fungal endocarditis: evidence in the world literature,
1965-1995</article-title><source>Clin Infect Dis</source><year>2001</year><volume>32</volume><issue>1</issue><fpage>50</fpage><lpage>62</lpage><pub-id pub-id-type="pmid">11118386</pub-id></element-citation></ref><ref id="r2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Millar</surname><given-names>BC</given-names></name><name><surname>Jugo</surname><given-names>J</given-names></name><name><surname>Moore</surname><given-names>JE</given-names></name></person-group><article-title>Fungal endocarditis in neonates and children</article-title><source>Pediatr Cardiol</source><year>2005</year><volume>26</volume><issue>5</issue><fpage>517</fpage><lpage>536</lpage><pub-id pub-id-type="pmid">15549616</pub-id></element-citation></ref><ref id="r3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>A&#x0011f;&#x00131;n</surname><given-names>H</given-names></name><name><surname>Devrim</surname><given-names>I</given-names></name><name><surname>&#x00130;&#x0015f;g&#x000fc;der</surname><given-names>R</given-names></name><name><surname>Karaarslan</surname><given-names>U</given-names></name><name><surname>Kan&#x00131;k</surname><given-names>E</given-names></name><name><surname>G&#x000fc;nay</surname><given-names>I</given-names></name><etal/></person-group><article-title>Risk factors for candidemia in pediatric intensive care unit
patients</article-title><source>Indian J Pediatr</source><year>2014</year><volume>81</volume><issue>11</issue><fpage>1158</fpage><lpage>1162</lpage><pub-id pub-id-type="pmid">24623095</pub-id></element-citation></ref><ref id="r4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Horn</surname><given-names>DL</given-names></name><name><surname>Neofytos</surname><given-names>D</given-names></name><name><surname>Anaissie</surname><given-names>EJ</given-names></name><name><surname>Fishman</surname><given-names>JA</given-names></name><name><surname>Steinbach</surname><given-names>WJ</given-names></name><name><surname>Olyaei</surname><given-names>AJ</given-names></name><etal/></person-group><article-title>Epidemiology and outcomes of candidemia in 2019 patients: data
from the prospective antifungal therapy alliance registry</article-title><source>Clin Infect Dis</source><year>2009</year><volume>48</volume><issue>12</issue><fpage>1695</fpage><lpage>1703</lpage><pub-id pub-id-type="pmid">19441981</pub-id></element-citation></ref><ref id="r5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pappas</surname><given-names>PG</given-names></name><name><surname>Rex</surname><given-names>JH</given-names></name><name><surname>Sobel</surname><given-names>JD</given-names></name><name><surname>Filler</surname><given-names>SG</given-names></name><name><surname>Dismukes</surname><given-names>WE</given-names></name><name><surname>Walsh</surname><given-names>TJ</given-names></name><etal/></person-group><article-title>Guidelines for treatment of candidiasis</article-title><source>Clin Infect Dis</source><year>2004</year><volume>38</volume><issue>2</issue><fpage>161</fpage><lpage>189</lpage><pub-id pub-id-type="pmid">14699449</pub-id></element-citation></ref><ref id="r6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nazarian</surname><given-names>M</given-names></name><name><surname>McCullough</surname><given-names>GH</given-names></name><name><surname>Fielder</surname><given-names>DL</given-names></name></person-group><article-title>Bacterial endocarditis in pregnancy: successful surgical
correction</article-title><source>J Thorac Cardiovasc Surg</source><year>1976</year><volume>71</volume><issue>6</issue><fpage>880</fpage><lpage>883</lpage><pub-id pub-id-type="pmid">818452</pub-id></element-citation></ref><ref id="r7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baddley</surname><given-names>JW</given-names></name><name><surname>Pappas</surname><given-names>PG</given-names></name></person-group><article-title>Antifungal combination therapy: clinical
potential</article-title><source>Drugs</source><year>2005</year><volume>65</volume><issue>11</issue><fpage>1461</fpage><lpage>1480</lpage><pub-id pub-id-type="pmid">16033288</pub-id></element-citation></ref><ref id="r8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baddley</surname><given-names>JW</given-names></name><name><surname>Benjamin Jr</surname><given-names>DK</given-names></name><name><surname>Patel</surname><given-names>M</given-names></name><name><surname>Mir&#x000f3;</surname><given-names>J</given-names></name><name><surname>Athan</surname><given-names>E</given-names></name><name><surname>Barsic</surname><given-names>B</given-names></name><etal/><collab>International Collaboration on Endocarditis-Prospective Cohort Study
Group (ICE-PCS)</collab></person-group><article-title>Candida infective endocarditis</article-title><source>Eur J Clin Microbiol Infect Dis</source><year>2008</year><volume>27</volume><issue>7</issue><fpage>519</fpage><lpage>529</lpage><pub-id pub-id-type="pmid">18283504</pub-id></element-citation></ref><ref id="r9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lefort</surname><given-names>A</given-names></name><name><surname>Chartier</surname><given-names>L</given-names></name><name><surname>Sendid</surname><given-names>B</given-names></name><name><surname>Wolff</surname><given-names>M</given-names></name><name><surname>Mainardi</surname><given-names>JL</given-names></name><name><surname>Podglajen</surname><given-names>I</given-names></name><etal/><collab>French Mycosis Study Group</collab></person-group><article-title>Diagnosis, management and outcome of Candida
endocarditis</article-title><source>Clin Microbiol Infect</source><year>2012</year><volume>18</volume><issue>4</issue><fpage>E99</fpage><lpage>E109</lpage><pub-id pub-id-type="pmid">22329526</pub-id></element-citation></ref><ref id="r10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pierrotti</surname><given-names>LC</given-names></name><name><surname>Baddour</surname><given-names>LM</given-names></name></person-group><article-title>Fungal endocarditis, 1995-2000</article-title><source>Chest</source><year>2002</year><volume>122</volume><issue>1</issue><fpage>302</fpage><lpage>310</lpage><pub-id pub-id-type="pmid">12114375</pub-id></element-citation></ref><ref id="r11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Benjamin Jr</surname><given-names>DK</given-names></name><name><surname>Miro</surname><given-names>JM</given-names></name><name><surname>Hoen</surname><given-names>B</given-names></name><name><surname>Steinbach</surname><given-names>WJ</given-names></name><name><surname>Fowler Jr</surname><given-names>VG</given-names></name><name><surname>Olaison</surname><given-names>L</given-names></name><etal/><collab>ICE-MD Study Group</collab></person-group><article-title>Candida endocarditis: contemporary cases from the International
Collaboration of Infectious Endocarditis Merged Database
(ICE-mD)</article-title><source>Scand J Infect Dis</source><year>2004</year><volume>36</volume><issue>6-7</issue><fpage>453</fpage><lpage>455</lpage><pub-id pub-id-type="pmid">15307567</pub-id></element-citation></ref><ref id="r12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Falcone</surname><given-names>M</given-names></name><name><surname>Barzaghi</surname><given-names>N</given-names></name><name><surname>Carosi</surname><given-names>G</given-names></name><name><surname>Grossi</surname><given-names>P</given-names></name><name><surname>Minoli</surname><given-names>L</given-names></name><name><surname>Ravasio</surname><given-names>V</given-names></name><etal/><collab>Italian Study on Endocarditis</collab></person-group><article-title>Candida infective endocarditis: report of 15 cases from a
prospective multicenter study</article-title><source>Medicine (Baltimore)</source><year>2009</year><volume>88</volume><issue>3</issue><fpage>160</fpage><lpage>168</lpage><pub-id pub-id-type="pmid">19440119</pub-id></element-citation></ref><ref id="r13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>JS</given-names></name><name><surname>Sexton</surname><given-names>DJ</given-names></name><name><surname>Mick</surname><given-names>N</given-names></name><name><surname>Nettles</surname><given-names>R</given-names></name><name><surname>Fowler Jr</surname><given-names>VG</given-names></name><etal/></person-group><article-title>Proposed modifications to the Duke criteria for the diagnosis of
infective endocarditis</article-title><source>Clin Infect Dis</source><year>2000</year><volume>30</volume><issue>4</issue><fpage>633</fpage><lpage>638</lpage><pub-id pub-id-type="pmid">10770721</pub-id></element-citation></ref><ref id="r14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Durack</surname><given-names>DT</given-names></name><name><surname>Lukes</surname><given-names>AS</given-names></name><name><surname>Bright</surname><given-names>DK</given-names></name></person-group><article-title>New criteria for diagnosis of infective endocarditis: utilization
of specific echocardiographic findings. Duke Endocarditis
Service</article-title><source>Am J Med</source><year>1994</year><volume>96</volume><issue>3</issue><fpage>200</fpage><lpage>209</lpage><pub-id pub-id-type="pmid">8154507</pub-id></element-citation></ref><ref id="r15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Martin</surname><given-names>GS</given-names></name><name><surname>Mannino</surname><given-names>DM</given-names></name><name><surname>Eaton</surname><given-names>S</given-names></name><name><surname>Moss</surname><given-names>M</given-names></name></person-group><article-title>The epidemiology of sepsis in the United States from 1979 through
2000</article-title><source>N Engl J Med</source><year>2003</year><volume>348</volume><issue>16</issue><fpage>1546</fpage><lpage>1554</lpage><pub-id pub-id-type="pmid">12700374</pub-id></element-citation></ref><ref id="r16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chang</surname><given-names>A</given-names></name><name><surname>Neofytos</surname><given-names>D</given-names></name><name><surname>Horn</surname><given-names>D</given-names></name></person-group><article-title>Candidemia in the 21st century</article-title><source>Future Microbiol</source><year>2008</year><volume>3</volume><issue>4</issue><fpage>463</fpage><lpage>472</lpage><pub-id pub-id-type="pmid">18651817</pub-id></element-citation></ref><ref id="r17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Roilides</surname><given-names>E</given-names></name><name><surname>Farmaki</surname><given-names>E</given-names></name><name><surname>Evdoridou</surname><given-names>J</given-names></name><name><surname>Dotis</surname><given-names>J</given-names></name><name><surname>Hatziioannidis</surname><given-names>E</given-names></name><name><surname>Tsivitanidou</surname><given-names>M</given-names></name><etal/></person-group><article-title>Neonatal candidiasis: analysis of epidemiology, drug
susceptibility, and molecular typing of causative isolates</article-title><source>Eur J Clin Microbiol Infect Dis</source><year>2004</year><volume>23</volume><issue>10</issue><fpage>745</fpage><lpage>750</lpage><pub-id pub-id-type="pmid">15605181</pub-id></element-citation></ref><ref id="r18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Celebi</surname><given-names>S</given-names></name><name><surname>Hacimustafaoglu</surname><given-names>M</given-names></name><name><surname>Ozdemir</surname><given-names>O</given-names></name><name><surname>Ozkaya</surname><given-names>G</given-names></name></person-group><article-title>Nosocomial candidaemia in children: results of a 9-year
study</article-title><source>Mycoses</source><year>2008</year><volume>51</volume><issue>3</issue><fpage>248</fpage><lpage>257</lpage><pub-id pub-id-type="pmid">18399906</pub-id></element-citation></ref><ref id="r19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pfaller</surname><given-names>MA</given-names></name><name><surname>Diekema</surname><given-names>DJ</given-names></name></person-group><article-title>Epidemiology of invasive candidiasis: a persistent public health
problem</article-title><source>Clin Microbiol Rev</source><year>2007</year><volume>20</volume><issue>1</issue><fpage>133</fpage><lpage>163</lpage><pub-id pub-id-type="pmid">17223626</pub-id></element-citation></ref><ref id="r20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Conde-Rosa</surname><given-names>A</given-names></name><name><surname>Amador</surname><given-names>R</given-names></name><name><surname>P&#x000e9;rez-Torres</surname><given-names>D</given-names></name><name><surname>Col&#x000f3;n</surname><given-names>E</given-names></name><name><surname>S&#x000e1;nchez-Rivera</surname><given-names>C</given-names></name><name><surname>Nieves-Plaza</surname><given-names>M</given-names></name><etal/></person-group><article-title>Candidemia distribution, associated risk factors, and attributed
mortality at a university-based medical center</article-title><source>P R Health Sci J</source><year>2010</year><volume>29</volume><issue>1</issue><fpage>26</fpage><lpage>29</lpage><pub-id pub-id-type="pmid">20222330</pub-id></element-citation></ref><ref id="r21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zaoutis</surname><given-names>T</given-names></name></person-group><article-title>Candidemia in children</article-title><source>Curr Med Res Opin</source><year>2010</year><volume>26</volume><issue>7</issue><fpage>1761</fpage><lpage>1768</lpage><pub-id pub-id-type="pmid">20513207</pub-id></element-citation></ref><ref id="r22"><label>22</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Baltimore</surname><given-names>RS</given-names></name></person-group><chapter-title>Infective endocarditis</chapter-title><person-group person-group-type="editor"><name><surname>Jenson</surname><given-names>HB</given-names></name><name><surname>Baltimore</surname><given-names>RS</given-names></name></person-group><source>Pediatric &#x00131;nfectious diseases: principles and practice</source><edition>2nd ed.</edition><publisher-loc>Norwalk</publisher-loc><publisher-name>Appleton &#x00026; Lange</publisher-name><year>2002</year><fpage>845</fpage><lpage>856</lpage></element-citation></ref><ref id="r23"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Puig-Asensio</surname><given-names>M</given-names></name><name><surname>Padilla</surname><given-names>B</given-names></name><name><surname>Garnacho-Montero</surname><given-names>J</given-names></name><name><surname>Zaragoza</surname><given-names>O</given-names></name><name><surname>Aguado</surname><given-names>JM</given-names></name><name><surname>Zaragoza</surname><given-names>R</given-names></name><etal/></person-group><article-title>Epidemiology and predictive factors for early and late mortality
in Candida bloodstream infections: a population-based surveillance in
Spain</article-title><source>Clin Microbiol Infect</source><year>2014</year><volume>20</volume><issue>4</issue><fpage>O245</fpage><lpage>O254</lpage><pub-id pub-id-type="pmid">24125548</pub-id></element-citation></ref><ref id="r24"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Simon</surname><given-names>MS</given-names></name><name><surname>Somersan</surname><given-names>S</given-names></name><name><surname>Singh</surname><given-names>HK</given-names></name><name><surname>Hartman</surname><given-names>B</given-names></name><name><surname>Wickes</surname><given-names>BL</given-names></name><name><surname>Jenkins</surname><given-names>SG</given-names></name><etal/></person-group><article-title>Endocarditis caused by Rhodotorula infection</article-title><source>J Clin Microbiol</source><year>2014</year><volume>52</volume><issue>1</issue><fpage>374</fpage><lpage>378</lpage><pub-id pub-id-type="pmid">24197888</pub-id></element-citation></ref><ref id="r25"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alhaji</surname><given-names>M</given-names></name><name><surname>Sadikot</surname><given-names>RT</given-names></name></person-group><article-title>Cryptococcal endocarditis</article-title><source>South Med J</source><year>201</year><volume>104</volume><issue>5</issue><fpage>363</fpage><lpage>364</lpage><pub-id pub-id-type="pmid">21606721</pub-id></element-citation></ref><ref id="r26"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cornely</surname><given-names>OA</given-names></name><name><surname>Bassetti</surname><given-names>M</given-names></name><name><surname>Calandra</surname><given-names>T</given-names></name><name><surname>Garbino</surname><given-names>J</given-names></name><name><surname>Kullberg</surname><given-names>BJ</given-names></name><name><surname>Lortholary</surname><given-names>O</given-names></name><etal/><collab>ESCMID Fungal Infection Study Group</collab></person-group><article-title>ESCMID guideline for the diagnosis and management of Candida
diseases 2012: non-neutropenic adult patients</article-title><source>Clin Microbiol Infect</source><year>2012</year><volume>18</volume><issue>Suppl 7</issue><fpage>19</fpage><lpage>37</lpage><pub-id pub-id-type="pmid">23137135</pub-id></element-citation></ref><ref id="r27"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Smego Jr</surname><given-names>RA</given-names></name><name><surname>Ahmad</surname><given-names>H</given-names></name></person-group><article-title>The role of fluconazole in the treatment of Candida endocarditis:
a meta-analysis</article-title><source>Medicine (Baltimore)</source><year>2011</year><volume>90</volume><issue>4</issue><fpage>237</fpage><lpage>249</lpage><pub-id pub-id-type="pmid">21694646</pub-id></element-citation></ref><ref id="r28"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pappas</surname><given-names>PG</given-names></name><name><surname>Kauffman</surname><given-names>CA</given-names></name><name><surname>Andes</surname><given-names>D</given-names></name><name><surname>Benjamin Jr</surname><given-names>DK</given-names></name><name><surname>Calandra</surname><given-names>TF</given-names></name><name><surname>Edwards Jr</surname><given-names>JE</given-names></name><etal/><collab>Infectious Diseases Society of America</collab></person-group><article-title>Clinical practice guidelines for the management of candidiasis:
2009 update by the Infectious Diseases Society of America</article-title><source>Clin Infect Dis</source><year>2009</year><volume>48</volume><issue>5</issue><fpage>503</fpage><lpage>535</lpage><pub-id pub-id-type="pmid">19191635</pub-id></element-citation></ref><ref id="r29"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Devathi</surname><given-names>S</given-names></name><name><surname>Curry</surname><given-names>B</given-names></name><name><surname>Doshi</surname><given-names>S</given-names></name></person-group><article-title>Isolated pulmonary valve infective endocarditis in a middle aged
man caused by Candida albicans: a case report</article-title><source>BMC Infect Dis</source><year>2014</year><volume>14</volume><fpage>557</fpage><lpage>557</lpage><pub-id pub-id-type="pmid">25358458</pub-id></element-citation></ref><ref id="r30"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yuan</surname><given-names>SM</given-names></name></person-group><article-title>Fungal endocarditis</article-title><source>Braz J Cardiovasc Surg</source><year>2016</year><volume>31</volume><issue>3</issue><fpage>252</fpage><lpage>255</lpage><pub-id pub-id-type="pmid">27737409</pub-id></element-citation></ref><ref id="r31"><label>31</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Steinbach</surname><given-names>WJ</given-names></name><name><surname>Perfect</surname><given-names>JR</given-names></name><name><surname>Cabell</surname><given-names>CH</given-names></name><name><surname>Fowler</surname><given-names>VG</given-names></name><name><surname>Corey</surname><given-names>GR</given-names></name><name><surname>Li</surname><given-names>JS</given-names></name><etal/></person-group><article-title>A meta-analysis of medical versus surgical therapy for Candida
endocarditis</article-title><source>J Infect</source><year>2005</year><volume>51</volume><issue>3</issue><fpage>230</fpage><lpage>247</lpage><pub-id pub-id-type="pmid">16230221</pub-id></element-citation></ref><ref id="r32"><label>32</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arnold</surname><given-names>CJ</given-names></name><name><surname>Johnson</surname><given-names>M</given-names></name><name><surname>Bayer</surname><given-names>AS</given-names></name><name><surname>Bradley</surname><given-names>S</given-names></name><name><surname>Giannitsioti</surname><given-names>E</given-names></name><name><surname>Mir&#x000f3;</surname><given-names>JM</given-names></name><etal/></person-group><article-title>Candida infective endocarditis: an observational cohort study
with a focus on therapy</article-title><source>Antimicrob Agents Chemother</source><year>2015</year><volume>59</volume><issue>4</issue><fpage>2365</fpage><lpage>2373</lpage><pub-id pub-id-type="pmid">25645855</pub-id></element-citation></ref></ref-list></back></article>